The following is a summary of “Submacular hemorrhage rates following anti-vascular endothelial growth factor injections for ...

An investigational antibody demonstrated an ability to preserve vision in people with geographic atrophy from dry age-related ...

Pharmaceuticals announced that the first patient has been dosed in the Phase 3 LUGANO clinical trial of DURAVYU, formerly ...

Preliminary data from a late stage clinical trial of a retinal implant showed promising results, Science Corporation said ...

CHICAGO -- Availability of a bevacizumab biosimilar for ophthalmic use could eliminate a lower-cost treatment option for a ...

Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...

Our eyes are precious, allowing us to experience the world around us. Maintaining good eye health is crucial for a fulfilling ...

Jefferies analyst Peter Welford noted that Roche’s pharma group came just slightly ahead of consensus expectations, driven by ...

A new statistical models shed light on why some patients can extend the dosing interval with Eylea (aflibercept) from 8 weeks ...

Light therapy could be a useful treatment for the most common form of age-related macular degeneration, a new study says.

CHICAGO -- An artificial intelligence (AI)-based study of home monitoring for neovascular age-related macular degeneration ...

The fight against Age Related Molecular Degeneration Market is seeing a promising boost. According to a recent analysis, the ...